{"id":"01a1df67-318c-7c5b-b747-91fdfe1f53e1","name":"NPPA trade margin cap on 137 non-scheduled anti-cancer drugs","situation_type":"regulatory_pressure","status":"active","start_date":"2026-10-17","end_date":null,"confidence":0.95,"member_count":3,"summary":"Three near-identical reports dated 2026-10-17 describe the same regulatory action: NPPA capping the trade margin on 137 non-scheduled anti-cancer drugs at 30% of MRP. The members differ only in wording (drugs, medicines), indicating a single real-world event reported in parallel.","place":null,"places":[],"intensity":null,"unknowns":[],"known_at":"2026-11-15T13:30:44.489558Z","actors":[],"members":[{"kind":"decision","id":"01a1df47-543f-7ead-a13c-7504fe75a0b6","title":"NPPA caps trade margin on 137 anti-cancer non-scheduled drugs at 30% of MRP","type_code":"regulate","status":"adopted","date":"2026-10-17","role":"part_of"},{"kind":"decision","id":"01a1df49-a451-78f5-afac-5851dd85817f","title":"NPPA caps trade margin on 137 non-scheduled anti-cancer drugs at 30% of MRP","type_code":"regulate","status":"adopted","date":"2026-10-17","role":"part_of"},{"kind":"decision","id":"01a1df4d-5911-70a7-b913-9de5745d10de","title":"NPPA caps trade margin on 137 non-scheduled anti-cancer medicines at 30% of MRP","type_code":"regulate","status":"adopted","date":"2026-10-17","role":"part_of"}],"evidence":null}